Los Angeles, CA – January 27, 2026 -The Terasaki Institute is pleased to announce the winners of its 2025 Media Contest, themed “Shaping Life, One Breakthrough at a Time.” This year’s entries celebrated the innovative spirit driving advances in healthcare, capturing moments where discovery, technology, and impact intersect, from lab-bench breakthroughs to real-world applications shaping the future of health and medicine.
Los Angeles, CA – December 22, 2025 -The Terasaki Institute for Biomedical Innovation (TIBI) concludes 2025 with a renewed sense of purpose and momentum. Following a year marked by scientific discoveries, community connections, and institutional resilience, the Institute continued to advance its mission of developing personalized, translational solutions that improve human health. Across cancer biology, regenerative medicine, immunoengineering, biosensing, and global collaboration, TIBI’s researchers, partners, and students demonstrated exceptional dedication to building a healthier future.
Los Angeles, CA – December 4, 2025 -Dr. Vadim Jucaud’s lab at the Terasaki Institute has introduced a new organ-on-a-chip platform that recapitulates age-dependent immune responses, offering a more accurate testing bed for evaluating cancer vaccine performance in older adults, the population most affected by cancer and often overlooked in traditional preclinical testing.
Los Angeles, CA – November 14, 2025 -The Terasaki Institute for Biomedical Innovation (TIBI) is pleased to announce its collaboration with the California Institute of Technology (Caltech) on a newly awarded $2.8 million Discovery Stage Research (DISC0) grant from the California Institute for Regenerative Medicine (CIRM).
Los Angeles, CA – November 11, 2025 -The Terasaki Institute for Biomedical Innovation recently hosted a special Fireside Chat titled “Remembering Dr. Paul I. Terasaki”, honoring the extraordinary life and legacy of Dr. Paul I. Terasaki. The discussion brought together distinguished leaders who spoke about Dr. Terasaki’s impactful work across academia, medicine, and entrepreneurship.
Los Angeles, CA – November 7, 2025 -The Terasaki Institute proudly announces that Johnson V. John, Ph.D., Assistant Professor at the Institute, has been appointed as a standing member of the Musculoskeletal Tissue Engineering (MTE) Study Section within the Center for Scientific Review at the National Institutes of Health (NIH). His four-year term is scheduled to begin in November 2025.
Los Angeles, CA – October 21, 2025 - The Terasaki Institute had the honor of hosting the Royal Belgian Economic Mission this past week, marking a significant step forward in fostering international collaboration between Belgium and California’s biomedical communities. The delegation’s visit to the Institute’s Woodland Hills facility was part of a larger program organized by the Belgian Foreign Trade Agency (BFTA) and Flanders Investment & Trade (FIT).
Los Angeles, CA – October 2, 2025 - The Terasaki Institute for Biomedical Innovation (TIBI) announces a leadership transition as Dr. Ali Khademhosseini concluded his tenure as Chief Executive Officer and Executive Director. He is pursuing entrepreneurial ventures at the intersection of artificial intelligence and biomedical innovation. We wish Dr. Khademhosseini well in his future endeavors.